Markets
Technology‑enabled home healthcare pioneer celebrates ongoing expansion – easing NHS pressures and advancing preventative care across the UK MONDAY 12 MAY 2025, LONDON, UK: Cera, the UK’s leading digital-first home healthcare provider, today announces new milestones in its rapid expansion, as it continues its journey to transform healthcare through technology. Cera, which launched in 2016, [...]
We round up the big ageing research news from the past week Researchers uncover surprising link to stroke risk Divorce can take a toll on children’s mental health, but new research reports that its effects may last far longer than expected, potentially increasing the risk of serious health issues decades later. According to findings, Americans [...]
Agetech World explores the latest investment developments in healthy ageing and longevity. US$10m to develop cell reset therapeutics for longevity Biotech company Junevity has raised US$10m in seed funding to accelerate its Junevity RESET platform. The platform is based on exclusively licensed research by co-founder Dr. Janine Sengstack at the University of California at San [...]
Biotechnology company Junevity has raised $10m in funding to advance its RESET platform, which uses large-scale human data and AI to identify genes – or transcription factors – that can regulate cell damage, and to develop its first therapeutic candidates in Type 2 diabetes, obesity and frailty. Diseases like obesity, diabetes, frailty, neurodegeneration and many [...]
Agetech World explores the latest investment developments in the world of healthcare and age technology. €35m to expand AI-enabled technology across senior care facilities globally Corporate venture firm of Angelini Industries, Angelini Ventures, has co-led an oversubscribed €35m Series B financing round in Nobi, an AgeTech company tackling global ageing challenges. Nobi is working to [...]
The Icelandic drug discovery firm Arctic Therapeutics, which is pioneering new treatments for dementia, has raised €26.5m in investment to advance its work. The new funding will enable the exploration of the potential of AT-001, an oral treatment designed to prevent the aggregation of harmful amyloid proteins in the brain, in other forms of familial [...]
Tune Therapeutics has raised US$175m in financing that will go toward advancing its epigenome editing clinical programme. The funding will accelerate the development of the company’s existing pipeline, currently anchored by Tune-401 – its clinical-stage epigenetic silencing drug for chronic Hepatitis B (HBV). It will also support the development of additional gene, cell, and regenerative [...]
Myant Corp has acquired digital health company mmHg in an acquisition that aims to accelerate personalised, AI-enabled remote healthcare. mmHg is a digital health company specialising in remote blood pressure monitoring, cardiovascular risk reduction, and chronic disease management. Myant's has said the deal will expand its geographic footprint and market reach to the USA, where [...]
Older people in the US are increasingly interested in using technology to age well and independently in their current homes and communities, A new report has revealed. The report found that 80 per cent of older Americans currently own at least one type of tech that enables ageing at home, and over half express a [...]
Shares of agetech company BioAge have plummeted since the company announced the discontinuation of a Phase 2 trial for its weight-loss drug azelaprag due to safety concerns. The abrupt halt comes just a little over two months after the company raised US$198m in an initial public offering in late September. Hagens Berman has opened an [...]
